Skip to main content

Avidity Partners Management LP

Source: SEC Form 13F · as of Mar 2026

Avidity Partners Management LP holds 36 biotech & pharma companies tracked by BioSniper, totaling $842.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

36

Total value held

$842.4M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Dianthus Therapeutics, Inc. /DE/ (DNTH)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
DNTHDianthus Therapeutics, Inc. /DE/4,208,368$361.3M
ORKAOruka Therapeutics, Inc.1,520,848$89.3M
CGONCG Oncology, Inc.1,288,948$87.2M
JBIOJade Biosciences, Inc.2,801,416$53.9M
CATXPerspective Therapeutics, Inc.12,099,998$48.8M
ELVNEnliven Therapeutics, Inc.800,000$32.2M
CNTXContext Therapeutics Inc.9,996,534$24.9M
TEVATeva Pharmaceutical Industries Limited650,100$20.6M
RGENREPLIGEN CORP155,600$18.4M
PVLAPALVELLA THERAPEUTICS, INC.140,000$17.7M
AKTSAktis Oncology Inc.937,132$17.2M
VIRVir Biotechnology, Inc.1,569,300$14.8M
KPTIKaryopharm Therapeutics Inc.927,482$6.4M
PHATPhathom Pharmaceuticals, Inc.498,780$5.6M
GILDGILEAD SCIENCES, INC.40,000$5.4M
MSLESatellos Bioscience Inc.775,538$5.3M
SCYXSCYNEXIS INC4,163,320$3.8M
ICLRICON plc32,000$3.7M
GPCRStructure Therapeutics Inc.78,000$3.4M
CRVSCorvus Pharmaceuticals, Inc.230,000$3.4M
GMABGenmab A/S100,000$2.7M
CORTCORCEPT THERAPEUTICS INC60,000$2.6M
NTLAIntellia Therapeutics, Inc.150,000$2.0M
MLTXMoonLake Immunotherapeutics100,000$1.8M
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.10,000$1.7M
RVMDREVOLUTION MEDICINES, INC.15,000$1.5M
ABVXAbivax SA10,000$1.1M
ABUSArbutus Biopharma Corp250,000$1.1M
UNHUnitedHealth Group Incorporated Common Stock (DE)3,800$1.0M
ABTABBOTT LABORATORIES10,000$908K
BBOTBridgeBio Oncology Therapeutics, Inc.87,706$761K
BBIOBridgeBio Pharma, Inc.10,000$711K
ACADACADIA PHARMACEUTICALS INC25,934$580K
LEGNLegend Biotech Corp15,000$353K
SVRASavara Inc50,000$262K
TRVITrevi Therapeutics, Inc.13,320$171K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.